Benzinga·2025-08-20 12:27Group 1 - U.S. stock futures are slightly lower, with S&P 500 futures down approximately 0.1% [1] - La-Z-Boy Incorporated reported weaker-than-expected financial results for Q1 of fiscal 2026, leading to a significant drop in its share price [1][2] - La-Z-Boy expects Q2 revenue to be between $510 million and $530 million, below the estimate of $531.67 million, citing a challenging consumer and macroeconomic environment [2] Group 2 - James Hardie Industries plc shares fell 27% to $20.72 following disappointing quarterly financial results [4] - Celldex Therapeutics, Inc. shares decreased by 16.7% to $20.00 after reporting Phase 2 topline results for Barzolvolimab in Eosinophilic Esophagitis [4] - Alcon Inc. shares declined 12.3% to $79.06 after the company reduced its FY25 sales guidance [4] - Dycom Industries, Inc. shares fell 11% to $240.00 following its second-quarter results [4] - Target Corporation shares dipped 9.8% to $95.00 after its second-quarter earnings report, while reaffirming its 2025 outlook and announcing a new CEO [4] - enCore Energy Corp. shares decreased by 8.5% to $2.36 as the company priced its upsized $100 million convertible senior notes offering [4] - The Estée Lauder Companies Inc. shares fell 8.5% to $82.34 after reporting quarterly results [4] - Novavax, Inc. shares dropped 7% to $8.86 in pre-market trading [4]